"India has vibrant biotech, pharmaceutial sectors"
-Carl-Johan Ivarsson, president, Qlucore
The Swedish company
Qlucore was founded in early 2007 and the first product released was
the ‘Qlucore Gene Expression Explorer'. The bioinformatics
software developer has recently entered the Indian market by signing an
agreement with JH BIO Innovations, a specialist Indian distribution
company that caters to major pharmaceutical companies, research
institutes, and universities in India.
Qlucore has received a
warm welcome from the Indian market with many companies downloading
trial versions of its data analysis software. Qlucore’s
latest software, Qlucore Omics Explorer, has been developed for the
life science, agricultural and biotech industry. With its highly
intuitive user interface, Qlucore Omics Explorer allows researchers
to shorten analysis time and add more creativity to research,
thanks to the product’s instant response and statistical
In an exclusive
interview with BioSpectrum, Carl-Johan Ivarsson, president, Qlucore
shares more insights.
Can you tell us about
Qlucore Omics Explorer and its applications?
Qlucore Omics Explorer is an enhanced data analysis tool that has been
developed for the life science and biotech industries. It allows
scientists and biologists to explore different hypotheses and
alternative scenarios within seconds. The software is therefore
invaluable for unveiling important new discoveries, as it allows the
actual researchers, the people with the most biological insight, to
study the data and to look for patterns and structures, without the
help of statistics or computer expert. The product can be used on any
multivariate data, including data from gene expression, protein array,
DNA methylation and proteomics experiments.
Who funded the
Qlucore started as a collaborative research project at Lund University,
Sweden, supported by researchers at the departments of mathematics and
clinical genetics, in order to address the vast amount of
high-dimensional data generated with microarray gene expression
analysis. Today, Qlucore remains as a privately-owned company that is
committed to achieving this same goal through a dedicated program of
Can you elaborate on
Qlucore’s growth plan?
Qlucore currently has customers in eight countries, and we are doubling
our sales each year. We expect to sustain this rate
of growth for the next few years.
What is the
company’s strategy for growth?
The first step is to create a broader awareness of Qlucore. This can be
achieved by working closely with our distributors, agents and other
strategic partners in selected countries.
Why is India an important
market for Qlucore?
India has vibrant and fast-growing biotech and pharmaceutical sectors.
As such, India is currently educating a lot of researchers in these and
other related areas, and the Qlucore software will play an important
role in their research.
Which are the other Asian
regions your products are marketed?
China will be the next big step, and we are already speaking to a
number of distributors and agents in this area.
Who are your major
Many well-known research institutions are currently using our software,
including the National Cancer Institute in the US, King’s
College London in the UK, France’s National Health Institute
(INSERM), as well as leading universities in both Sweden and Germany.
What will be the main
areas of focus for Qlucore?
We typically focus on data that is derived from life sciences industry,
but future possibilities could include virtually any project where the
amount of data being produced is very large, such as complex financial
Jahanara Parveen in